Ozari vs Sequence for GLP-1: Which Telehealth Provider Offers Better Value?

Sarah spent two hours last Tuesday comparing GLP-1 telehealth providers on her laptop, toggling between tabs and scribbling notes. She'd heard about the weight loss results from friends—one lost 34 pounds on semaglutide, another dropped three dress sizes on tirzepatide—but the pricing structures confused her. One provider quoted $297/month. Another said "as low as" a certain price but buried the actual costs in fine print. She wanted straight answers about what she'd actually pay and what kind of medical support she'd receive.

If you're weighing Ozari against Sequence for your GLP-1 prescription, you're probably asking the same questions Sarah did. Both companies offer telehealth access to semaglutide and tirzepatide, the medications behind Ozempic, Wegovy, Mounjaro, and Zepbound. Both promise convenience and affordability. But the similarities mostly end there.

The differences in pricing structure, medication sourcing, clinical support, and long-term value can mean hundreds of dollars and vastly different experiences over the course of your treatment. Let's break down what actually matters when you're choosing between these two providers.

The Real Cost Breakdown: What You'll Actually Pay

Pricing transparency separates good telehealth companies from ones that leave you guessing. Ozari's pricing model is straightforward: compounded semaglutide and tirzepatide start at $99/month. That's the actual monthly cost for the medication, shipping included. No hidden consultation fees. No surprise charges when you reach a higher dose.

Sequence takes a different approach. Their advertised pricing can appear lower initially, but the structure gets more complicated when you look closely. They offer both brand-name and compounded medications, which sounds like flexibility but often creates confusion about what you're actually getting. Their brand-name option (the actual Ozempic, Wegovy, Mounjaro, or Zepbound) depends entirely on your insurance coverage and can run $900-1,300/month without it. Their compounded option pricing varies based on dosage and specific formulation.

Here's what we see frequently in our patients who've switched from other providers: they thought they were getting one price but ended up paying significantly more as their dosage increased. With GLP-1 medications, you'll typically start at a lower dose and titrate up over several months. The STEP 1 trial protocol, for instance, escalated semaglutide doses over 16-20 weeks to reach the therapeutic 2.4 mg weekly dose. If your provider charges more at higher doses, your monthly cost isn't actually what they advertised.

Ozari maintains consistent pricing regardless of dose escalation. Whether you're on a starter dose of 0.25 mg semaglutide or the full 2.4 mg maintenance dose, the monthly rate stays at $99. Over a typical 12-month treatment course, that predictability matters enormously for budgeting.

There's also the consultation fee consideration. Some telehealth providers charge $49-99 for the initial medical consultation, then additional fees for follow-ups. Ozari includes the medical consultation in the service—you're not paying separately to talk to a prescriber. That's not just about saving $50 or $100 upfront. It means you won't hesitate to reach out when you have questions or concerns about side effects, which is exactly when you should be talking to a healthcare provider.

Medication Source and Quality: Compounded vs Brand-Name

Both Ozari and Sequence offer compounded GLP-1 medications, but understanding what "compounded" actually means is essential for making an informed choice. Compounded medications are made by specialized pharmacies using the same active ingredients as brand-name drugs—the same semaglutide molecule, the same tirzepatide peptide. They're not generic versions (those don't exist yet for GLP-1s). They're customized preparations made at licensed facilities.

The quality question comes down to pharmacy standards. Ozari partners exclusively with 503B FDA-registered outsourcing facilities. These aren't your neighborhood compounding pharmacies. They're large-scale operations that undergo regular FDA inspection, follow current good manufacturing practices (cGMP), and test every batch for sterility, potency, and purity. The 503B designation means they can produce larger quantities while maintaining pharmaceutical-grade quality standards.

Sequence also uses compounding pharmacies, though their specific sourcing and pharmacy partnerships are less clearly detailed on their platform. They offer both compounded and brand-name options, which creates a two-tier system. If you want the FDA-approved brand (Wegovy, Ozempic, Mounjaro, Zepbound), you'll pay dramatically more unless you have excellent insurance coverage. If you choose their compounded route, you'll get a lower price point but should ask specific questions about which pharmacies they use and what testing protocols they follow.

In our clinical experience, patients do equally well on high-quality compounded semaglutide and tirzepatide as they do on brand-name versions. The active ingredient is molecularly identical. What matters is the manufacturing quality, sterility assurance, and proper storage during shipping. We've seen average weight loss results with compounded semaglutide matching the STEP 1 trial outcomes: 14.9% body weight reduction over 68 weeks at the 2.4 mg dose.

One practical consideration: brand-name medications come in pre-filled, single-dose pens that you simply inject and discard. Compounded medications typically come in multi-dose vials that require you to draw up your dose with a syringe. Some patients strongly prefer the pen convenience. Others don't mind the extra 30 seconds to prepare a syringe, especially when it saves them $700-900 monthly. Neither method is more effective—it's purely about personal preference and budget.

Clinical Support and Access to Care

The quality of medical support varies dramatically between telehealth providers, and this is where many patients discover they didn't get what they expected. Ozari and Sequence both offer provider access, but the structure and responsiveness differ significantly.

Ozari provides ongoing access to licensed healthcare providers who specialize in metabolic health and GLP-1 therapy. When you have a question about side effects—say you're experiencing nausea or wondering if constipation is normal—you can message your care team through the patient portal. Response times are typically same-day or next-day, not the 3-5 business days you might see with larger, less specialized telehealth platforms.

This matters more than you might initially think. GLP-1 medications can cause side effects, especially in the first few weeks or when increasing doses. Nausea affects about 44% of people on semaglutide, according to STEP trial data. Knowing whether you should push through mild nausea, adjust your eating patterns, or actually reduce your dose requires medical judgment. Having a provider who responds quickly and understands these medications specifically makes the difference between tolerating treatment successfully and giving up after two weeks.

Sequence offers medical consultations through their platform as well, connecting you with licensed providers for your initial assessment and prescription. However, patient reviews suggest more variability in the ongoing support experience. Some users report excellent communication; others describe difficulty getting responses to follow-up questions or feeling like they're going through a more automated, less personalized process.

There's also the question of continuity. With Ozari, you're working with a care team that sees your complete history and tracks your progress over time. They know you started at 0.25 mg, had mild nausea the first week, felt great by week three, and are now ready to increase to 0.5 mg. That continuity creates better clinical decision-making than answering the same intake questions repeatedly with different providers who don't know your history.

Another consideration is what happens if you need to pause treatment or have a medical question outside business hours. We recommend asking any telehealth provider about their after-hours protocols and how they handle medication adjustments if you're experiencing significant side effects. The best providers have clear escalation pathways and clinical protocols, not just an email inbox that might sit unread over a long weekend.

The Prescription Process and Ongoing Management

Getting started with a GLP-1 telehealth provider should be straightforward, but the details of how prescriptions are managed over time reveal a lot about the company's operational quality. Both Ozari and Sequence handle the process remotely, but the efficiency and communication differ.

Ozari's onboarding starts with a medical intake form covering your health history, current medications, weight loss goals, and any contraindications for GLP-1 therapy. A licensed provider reviews your information, usually within 24 hours. If you're approved (most patients are, unless there are specific contraindications like a history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2), your prescription is sent to the compounding pharmacy and your first shipment typically arrives within 5-7 days.

The refill process is automated but supervised. Before each shipment, the care team checks in about your progress and any side effects. This serves two purposes: it ensures you're tolerating the medication well, and it gives your provider the clinical information needed to determine if you should stay at your current dose or increase. The SURMOUNT-1 trial protocol for tirzepatide, which showed average weight loss of 20.9% at the 15 mg dose, followed a careful escalation schedule over 20 weeks. Your provider should be following similar clinical judgment, not just automatically shipping the same dose forever or rushing you to higher doses too quickly.

Sequence follows a similar telehealth structure with intake, provider review, and prescription fulfillment. Where patients report differences is in the refill communication and dose adjustment process. Some describe a more hands-off approach where refills arrive automatically without much check-in about progress or tolerance. That's efficient if everything's going smoothly but potentially problematic if you're having side effects or feel ready to increase your dose.

One practical detail that matters: shipping discretion and reliability. GLP-1 medications need to stay refrigerated, so they ship with ice packs in insulated packaging. If you're not home when delivery arrives and the package sits in summer heat for eight hours, that's a problem. Ozari includes tracking and temperature monitoring with shipments, and the packaging is designed to maintain appropriate temperature for up to 48 hours. We tell our patients to plan for delivery days and arrange to be home or have a trusted neighbor grab the package if needed.

What Women Should Know

Women make up the majority of GLP-1 users for weight loss, and there are gender-specific considerations that your provider should address. If you're of childbearing age, you need clear guidance about pregnancy planning while on semaglutide or tirzepatide. The current recommendation is to discontinue GLP-1 medications at least two months before trying to conceive, based on animal studies showing potential risks. That's not always clearly communicated during the initial telehealth visit, but it absolutely should be.

Women also tend to experience nausea more frequently than men on these medications—some studies suggest rates 10-15% higher. Your provider should be proactively asking about nausea at each check-in and offering specific strategies: eating smaller meals, avoiding high-fat foods, staying well-hydrated, and sometimes temporarily reducing the dose. These aren't just comfort issues. Severe nausea can lead to dehydration and makes it much less likely you'll continue treatment long enough to see the full benefits.

Hormonal considerations matter too. Some women notice that GLP-1 medications affect their menstrual cycles, particularly if they're losing weight rapidly. This usually normalizes after a few months, but it's something to track and discuss with your provider. If you're perimenopausal or menopausal, the interaction between changing hormones and weight loss medications can be more complex. You want a care team that understands these nuances rather than a one-size-fits-all approach.

What Men Should Know

Men typically tolerate GLP-1 medications well and often see excellent results, but there are specific considerations worth knowing. The SELECT trial, which studied semaglutide's cardiovascular benefits, enrolled predominantly men with pre-existing cardiovascular disease. Results showed a 20% reduction in major cardiovascular events—heart attack, stroke, or cardiovascular death. If you have a history of heart disease or significant risk factors, that's a substantial benefit beyond just weight loss.

Men are more likely to have undiagnosed sleep apnea, especially at higher body weights. GLP-1-induced weight loss often improves or completely resolves sleep apnea, but this should be assessed and monitored. If you snore heavily, feel tired despite adequate sleep, or have been told you stop breathing during sleep, mention this specifically to your provider. Treating sleep apnea alongside weight loss can dramatically improve energy, mental clarity, and cardiovascular health.

There's also the practical reality that men often wait longer to seek help for weight issues and may come to GLP-1 therapy with more advanced metabolic problems—higher A1C levels, more significant hypertension, or established cardiovascular disease. That doesn't mean you're not a good candidate. It means you need a provider who's actually reviewing your medical history carefully and coordinating with your other doctors if you're on multiple medications for blood pressure, diabetes, or cholesterol. Those medications may need adjustment as you lose weight and your metabolic markers improve.

From the Ozari Care Team

We recommend approaching your GLP-1 provider decision the same way you'd choose any important healthcare partner—by asking direct questions and paying attention to how they respond. Ask what happens if you have side effects at 9 PM on a Saturday. Ask whether pricing changes as your dose increases. Ask which specific pharmacies compound their medications and what testing protocols they follow. A good provider will answer these questions clearly and thoroughly. A provider that gives vague responses or makes you feel like you're being difficult for asking is showing you who they are. In our experience, patients who feel genuinely supported by their care team—not just given a prescription and wished good luck—are far more likely to stick with treatment long enough to achieve meaningful, lasting results.

Key Takeaways

• Ozari offers transparent, flat-rate pricing at $99/month for compounded semaglutide and tirzepatide regardless of dose, while Sequence's pricing structure varies and can be more complex to navigate with both brand and compounded options
• Both providers use compounded medications, but Ozari exclusively partners with 503B FDA-registered facilities that follow pharmaceutical-grade manufacturing standards and regular FDA inspection protocols
• Clinical support quality varies significantly—look for providers offering same-day or next-day response times, continuity of care with providers who know your history, and proactive check-ins about side effects and progress
• The prescription management process should include medical oversight of dose escalation based on your tolerance and results, not just automatic refills without clinical assessment
• Total cost over a 12-month treatment course can differ by thousands of dollars between providers once you factor in consultation fees, dose-dependent pricing, and shipping costs

Frequently Asked Questions

Is compounded semaglutide from Ozari as effective as brand-name Wegovy or Ozempic?

Yes, when compounded by high-quality 503B pharmacies, semaglutide is molecularly identical to the brand-name versions. The active ingredient is the same peptide at the same concentration. What matters is manufacturing quality, sterility, and proper storage—areas where 503B facilities maintain pharmaceutical-grade standards with regular FDA oversight. In our clinical experience, patients achieve weight loss results matching the published trial data (average 14.9% body weight reduction at 2.4 mg dose) with properly compounded semaglutide. The main differences are packaging and price, not effectiveness.

Can I switch from Sequence to Ozari if I'm already on treatment?

Absolutely, and it's more straightforward than most people think. You'll complete Ozari's medical intake so our providers can review your history and current dose, then we'll continue your prescription at the same dose level you're currently taking. There's no need to restart at a lower dose or go through the escalation schedule again. Just time your switch so you're not left without medication between providers—ideally, start the Ozari intake process about two weeks before your current prescription runs out. Many of our patients have successfully switched from other telehealth providers without interrupting their treatment progress.

What happens if I experience serious side effects with Ozari?

You should contact the Ozari care team immediately through the patient portal or phone line, and we'll typically respond within hours for urgent concerns. Your provider can adjust your dose, recommend specific management strategies, or in rare cases, discontinue the medication if side effects are severe. For truly emergent situations—like signs of pancreatitis (severe abdominal pain), allergic reactions, or symptoms requiring immediate attention—you should go to an emergency room or call 911, just as you would with any medication. We'll follow up on any ER visits to coordinate your ongoing care and determine whether continuing GLP-1 therapy makes sense for you.

Does Ozari accept insurance or offer financing options?

Ozari's $99/month pricing is a direct-pay model and doesn't currently process insurance claims. However, this is often comparable to or better than insurance copays for brand-name GLP-1 medications, especially if your insurance doesn't cover them for weight loss or you haven't met your deductible. Some patients have successfully submitted receipts to their insurance for out-of-network reimbursement or used HSA/FSA funds for payment. The advantage of the direct-pay model is price transparency and no prior authorization hassles. You know exactly what you'll pay each month, and there's no waiting weeks for insurance approval while your motivation and momentum fade.

How long do most people stay on GLP-1 medications, and what happens when I stop?

Most patients stay on GLP-1 therapy for 12-18 months to achieve their weight loss goals, though some continue longer for weight maintenance. The STEP 1 trial followed patients for 68 weeks (about 16 months) and showed continued benefit throughout that period. When you discontinue, you'll work with your provider to taper off gradually rather than stopping abruptly. What happens next varies considerably by individual. Some patients maintain their weight loss through lifestyle changes and new habits established during treatment. Others regain some weight, which is why we emphasize using your time on medication to build sustainable eating patterns, regular physical activity, and behavioral changes that continue after you stop the medication. There's no shame in needing to restart treatment if weight starts creeping back—we see this as managing a chronic condition, not a single-course cure.

At Ozari Health, we offer compounded Semaglutide and Tirzepatide as low as $99/month, shipped to your door. Learn more at ozarihealth.com.